Skip to main content

Table 1

From: Effects of NRTI backbone on HIV RNA, CD4 counts and lipids for first-line boosted PI-based HAART: meta-analysis of 12 clinical trials in 4,896 patients

NRTI backbone TDF/FTC    ABC/3TC   
PI N RNA<50 95% CI N RNA<50 95% CI
LPV/r 2285 74% 72–76% 722 66% 63–70%
fAPV/r 53 75% 63–87% 722 67% 63–70%
ATV/r 493 79% 75–82% 112 77% 68–85%
SQV/r 166 65% 58–72% no data - -
DRV/r 343 84% 80–88% no data - -